The Finnish company will supply Open Radio Access Network technology as part of the agreement to roll out a new network in ...
Companies say shoppers are still buying, but they want a deal.
Roche said it will acquire Poseida Therapeutics at $9.00 per share, representing a total equity value of approximately $1.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback